You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Lymphoma Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 3 of 3

NCI/CIRB EAY131 Molecular Analysis for Therapy Choice (MATCH)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D'Amour Center For Cancer Care

3350 Main Street
Springfield, MA 01199

NCI/CIRB S1609 DART: DUAL ANTI-CTLA-4 AND ANTI-PD-1 BLOCKADE IN RARE TUMORS

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Baystate Franklin Medical Center
164 High Street
Greenfield, MA 01301

Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma

The purpose of this study is to find out what effects, good and/or bad, the addition of lenalidomide to standard chemotherapy (RCHOP)
Syed Ali, MD
Cancer - Lymphoma, Cancer

D’Amour Center for Cancer Care

3350 Main Street

Springfield MA 01199


 Franklin Medical Center

164 High Street

Greenfield MA


 

Page 1 of 1 | Results 1 - 3 of 3